Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520
Open Access
- 6 February 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 58 (1) , 182-191
Abstract
Metabolic changes are common features of many cancer cells and are frequently associated with the clinical outcome of patients with various cancers, including hepatocellular carcinoma (HCC). Thus, aberrant metabolic pathways in cancer cells are attractive targets for cancer therapy. However, our understanding of cancer-specific regulatory mechanisms of cell metabolism is still very limited. We found that Tat-activating regulatory DNA-binding protein (TARDBP) is a novel regulator of glycolysis in HCC cells. TARDBP regulates expression of the platelet isoform of phosphofructokinase (PFKP), the rate-limiting enzyme of glycolysis that catalyzes the irreversible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. Silencing of TARDBP expression in multiple HCC cell lines leads to impaired glucose metabolism and inhibition of in vitro and in vivo growth of HCC cells. Notably, the microRNA 520 (miR-520) family is an intermediate regulator of TARDBP-mediated regulation of glycolysis. Mechanistically, TARDBP suppressed expression of the miR-520 family, which, in turn, inhibited expression of PFKP. We further showed that expression of TARDBP is significantly associated with the overall survival of patients with HCC. Conclusion: Our study provides new mechanistic insights into the regulation of glycolysis in HCC cells and reveals TARDBP as a potential therapeutic target for HCC. (HEPATOLOGY 2013;)Keywords
This publication has 40 references indexed in Scilit:
- A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cellsThe EMBO Journal, 2012
- Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaNature Genetics, 2012
- Gains or losses: molecular mechanisms of TDP43-mediated neurodegenerationNature Reviews Neuroscience, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Therapeutic targeting of cancer cell metabolismJournal of Molecular Medicine, 2011
- Deletion of TDP-43 down-regulates Tbc1d1 , a gene linked to obesity, and alters body fat metabolismProceedings of the National Academy of Sciences, 2010
- Global expression analysis of miRNA gene cluster and family based on isomiRs from deep sequencing dataComputational Biology and Chemistry, 2010
- TAR DNA-binding protein 43 in neurodegenerative diseaseNature Reviews Neurology, 2010
- Knockdown of transactive response DNA‐binding protein (TDP‐43) downregulates histone deacetylase 6The EMBO Journal, 2009
- TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expressionProceedings of the National Academy of Sciences, 2008